110 S. Paca Street (Paca/Pratt), 7th floor
1997 BS, Mathematics, Howard University, Washington D.C.
2002 MS, Cellular and Molecular Biology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania
2003 MD, University of Pennsylvania, School of Medicine, Philadelphia, Pennsylvania
2008 MPH, Biostatistics, University North Carolina, Chapel Hill, North Carolina
2003-2004 Pediatric Internship, Duke University Medical Center
2004-2006 Pediatric Residency, Duke University Medical Center
2006-2008 Clinical Research Fellow, Duke Clinical Research Institute
2006-2010 Fellowship, Pediatric Cardiology, Duke University
2013-2014 Pediatric Heart Transplantation Observership, Children’s Hospital of Philadelphia
Dr. Carissa Baker-Smith MS, MPH, FAHA, FAAP, is a board certified pediatrician and pediatric cardiologist who specializes in prevention, quality improvement and advanced heart failure/pediatric transplantation. Dr. Baker-Smith was recognized as one of Baltimore’s Top Docs 2016. She is also the recipient of other awards, including the National Coalition of Black Women Torchbearer Award for her work in Pediatric Cardiology. After completing her undergraduate studies (major: mathematics) at Howard University in Washington DC, Dr. Baker-Smith attended the University of Pennsylvania School of Medicine, where she obtained her Medical Doctorate (MD) and then a master’s degree in Cellular and Molecular Biology. She carried out basic science work in the area of angiogenesis.
She went on to complete her pediatric residency and pediatric cardiology fellowship at Duke University Medical Center (Durham, NC). While completing her pediatric cardiology fellow at Duke, she simultaneously completed a research fellowship at the Duke Clinical Research Institute and a master’s of public health degree in Biostatistics at the University of North Carolina Chapel Hill. In 2010, Dr. Baker-Smith joined the faculty at the University of Maryland School of Medicine. Dr. Baker-Smith has combined her research training with her interest in quality improvement to design, implement (statistical analyses) and publish work related to quality improvement in children with congenital heart disease.
Dr. Baker-Smith is an active contributor to several quality improvement initiatives and national projects. She has served as a member of the National Pediatric Cardiology Quality Improvement Collaborative (NPC-QIC), the Congenital Heart Public Health Consortium, and Congenital heart disease advisory committee (CCHD) for implementation of pulse oximetry screening in the state of Maryland. She remains actively involved in several quality improvement initiatives, including creation of quality metrics for ambulatory care of children with congenital heart disease and she is a co-author of the 2017 pediatric hypertension guidelines, just to name a few.
Dr. Baker-Smith’s clinical interests include pediatric hypertension, cardiovascular genetics, and cardiac transplantation. Her currently research interests include pediatric hypertension, methods for assessing cardiovascular risk among youth using non-invasive approaches and improvements in the care and outcomes of pediatric cardiac transplantation patients. Dr. Baker-Smith is a consultant for the American Academy of Pediatrics. She is a fellow of the American Heart Association (FAHA), a fellow of the American Academy of Pediatrics (FAAP), and an active members of the American College of Cardiology (ACC) and the International Society for Heart and Lung Transplantation (ISHLT). She is a co- author of the American Academy of Pediatrics Education in Quality Improvement for Pediatric Practice (EQIPP)for Pediatric Hypertension and a selected member of the AHA Atherosclerosis, Hypertension, and Obesity in the Young (AHOY) committee.
Specialized care of patients with advanced heart failure and following heart transplantation; cardiovascular genetics
Binka E, Mendley S, Gaskin P, Himes C, Jinadu L, Baker-Smith CM. Description of AntiHypertensive Medication Use in a Pediatric Practice: single and multiple antihypertensive mediation therapy. J Clin Hypertension. Accepted for publication June 9, 2016.
Laliberte B, Reed BN, Ather A, Devabhakthuni S, Watson K, Lardieri AB, Baker-Smith CM. Safe and Effective Use of Pharmacologic and Device Therapy for Peripartum Cardiomyopathy. Pharmacotherapy. 2016 Jul 4 (available online).
Baker-Smith CM, Goldberg SW, Rosenthal GL. Predictors of Prolonged Hospital Length of Stay Following Stage II Palliation of Hypoplastic Left Heart Syndrome(and Variants): Analysis of the National Pediatric Cardiology Quality Improvement Collaborative (NPC-QIC) Database. Pediatr Cardiol. 2015 Jun 3.
Baker-Smith CM, Wilhelm CM, Neish SR, Klitzner TS, Beekman RH, Kugler JD,Martin GR, Lannon C, Jenkins KJ, Rosenthal GL. Predictors of Prolonged Length of Intensive Care Unit Stay After Stage I Palliation: A Report from the National Pediatric Cardiology Quality Improvement Collaborative. Pediatr Cardiol. 2014 Mar; 35(3):431-40.
Baker-Smith CM and Vashist S. Cardiac Arrest and Sudden Death in the Pediatric Population. Journal of Clinical and Experimental Cardiology. 2012.
12/2011- 12/2017 Childhood Obesity and Cardiovascular Health Initiative (COACH). Ronald McDonald House Charities Award $25,000